Acadian Asset Management’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Acadian Asset Management’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-62,956	Closed	-$434K	–	1922
2022 Q2	$434K	Buy	+62,956	New	+$442K	﹤0.01%	1020
2021 Q2	–	Sell	-51	Closed	-$1K	–	2289
2021 Q1	$1K	Sell	51 -2,368	-98%	-$85.4K	﹤0.01%	2027
2020 Q4	$84K	Hold	2,419	–	–	﹤0.01%	1805
2020 Q3	$121K	Buy	+2,419	New	+$97.8K	﹤0.01%	1607

Other funds holding FMTX

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

TAL

TIG Advisors LLC New York $2.16B AUM 72.99% 1-Year Est. Return

WIC

Water Island Capital New York $896M AUM 107.59% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return

FTCM

First Trust Capital Management Chicago, Illinois $1.9B AUM 58.39% 1-Year Est. Return

Acadian Asset Management's FMTX Position: Q3 2022 in Review

Acadian Asset Management sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q3 2022, closing a stake of 62,956 shares — an estimated $434K sold.

Acadian Asset Management first reported a position in FMTX in Q3 2020 and held it in 4 quarters. The position peaked at $434K in Q2 2022. 139 funds tracked by Wall St. Rank hold FMTX as of Q3 2022.

Acadian Asset Management reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
Acadian Asset Management sold 62,956 Forma Therapeutics Holdings, Inc. Common Stock shares in Q3 2022, an estimated $434K.
Acadian Asset Management first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2020 and held it in 4 quarters.
Acadian Asset Management's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $434K in Q2 2022.
139 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q3 2022.

Based on Acadian Asset Management's 13F filing for Q3 2022, filed 14 Nov 2022.